Imodium a-d and Strattera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium a-d (loperamide hydrochloride) and Strattera (atomoxetine hydrochloride). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Imodium a-d and Strattera. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium a-d?

Imodium a-d has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 8,944 Imodium a-d users. Check the latest studies of Imodium a-d.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

15 people who take Imodium a-d and Strattera together, and have interactions are studied.

Imodium a-d and Strattera drug interactions.

What are the common drug interactions of Imodium A-D and Strattera, by gender? *:

female:

Anxiety
Dizziness
Inflammation
Malaise (a feeling of general discomfort or uneasiness)
Migraine (headache)
Nasal dryness (dry nose)
Nausea (feeling of having an urge to vomit)
Rash
Strabismus (a disorder in which the two eyes do not line up in the same direction)
Trigger finger

male:

n/a

What are the common drug interactions of Imodium A-D and Strattera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Breast mass
Dizziness
Hyperhidrosis (abnormally increased sweating)
Malaise (a feeling of general discomfort or uneasiness)
Sinusitis (inflammation of sinus)

30-39:

Anxiety
Palpitations (feelings or sensations that your heart is pounding or racing)
Precancerous skin lesion
Surgery

40-49:

n/a

50-59:

Anxiety
Calcinosis (calcium deposits in any soft tissue)
Chest pain
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Heart rate irregular
Pancreatic carcinoma stage ii (pancreatic cancer stage ii)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 86.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 86.67%
Pain: 2 people, 13.33%
Hypersensitivity: 2 people, 13.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 13.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 13.33%
Drug Hypersensitivity: 2 people, 13.33%
Drowsiness: 2 people, 13.33%
Bipolar Disorder (mood disorder): 2 people, 13.33%
Asthma: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium a-d and Strattera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously